Management of Fibroepithelial Breast Lesions
When a fibroepithelial lesion is diagnosed on core needle biopsy, select patients may be suitable for monitoring instead of automatic surgical excision, though this requires careful radiologic-pathologic correlation 1.
Initial Evaluation Approach
The evaluation begins with ultrasound as the primary imaging modality to characterize the lesion 2. Key imaging features to document include:
- Size (lesions >4.5 cm have higher malignancy risk)
- Echo pattern (heterogeneous vs homogeneous)
- Shape and margins (oval/round circumscribed vs irregular)
- Growth rate if prior imaging available
Mammography or digital breast tomosynthesis should be performed for complete assessment, particularly in women ≥30 years 1.
Core Needle Biopsy Interpretation
When CNB returns as "fibroepithelial lesion," the pathology report should be scrutinized for high-risk features that predict phyllodes tumor upgrade 3, 4:
High-risk pathologic features:
- Stromal overgrowth
- Increased stromal cellularity
- Mitotic activity
- Leaf-like architecture
- Pathologist notation "favors phyllodes tumor"
Patient age ≥40 years is also an independent risk factor for phyllodes tumor 3.
Decision Algorithm for Surgical Excision vs Surveillance
Recommend Surgical Excision When:
- Any high-risk pathologic features present (stromal overgrowth, increased cellularity, mitoses, atypia) 1, 4
- Size >4.5 cm 4
- Heterogeneous echo pattern on ultrasound 4
- Pathology-imaging discordance 1
- Potential phyllodes tumor noted by pathologist 1
- Patient age ≥40 years with concerning features 3
The 2024 study by 4 developed a practical "SHO score" (Size >4.5cm, Heterogeneous echo, Overgrowth on CNB) - when all three are absent, the probability of borderline/malignant phyllodes is only 1%.
Consider Surveillance When ALL of the Following:
- Size ≤4.5 cm 4
- Homogeneous echo pattern 4
- No stromal overgrowth on CNB 4
- No other high-risk pathologic features 5
- Concordant imaging and pathology 1
- Patient age <40 years 3
Surveillance Protocol
For lesions selected for active surveillance 5:
- Physical examination with ultrasound every 6-12 months for 1-2 years 1
- Proceed to excision if:
The 2020 study by 5 demonstrated that 98% of excised fibroepithelial lesions were benign, and among those under surveillance, only 35% showed ≥50% volume increase at 2 years, with all later excisions proving benign.
Critical Pitfalls to Avoid
Do not rely on imaging alone - even benign-appearing lesions require tissue diagnosis when there are clinical concerns 2, 1.
Beware of sampling error - core needle biopsy may miss areas of phyllodes tumor in heterogeneous lesions, which is why high-risk features mandate excision 6, 7.
Age matters - while fibroadenomas peak at ages 20-30, phyllodes tumors are more common at ages 40-50 8. Apply more conservative thresholds for excision in older patients.
Growth is significant - any documented growth should prompt re-evaluation and strong consideration for excision 2, 1, 5.
Strength of Evidence
The NCCN guidelines 1 explicitly state that "select patients with fibroepithelial lesions may be suitable for monitoring in lieu of surgical excision," representing a shift from automatic excision. This is supported by recent research 5, 4 showing very low malignancy rates in appropriately selected cases. However, surgical consultation remains appropriate for shared decision-making, particularly in borderline cases 9.
The evidence strongly supports that most fibroepithelial lesions can be safely observed when they lack high-risk features, potentially sparing 70% of patients unnecessary surgery 4.